Skip to content
HomeLatest newsJohnson & Johnson Chairman and CEO Alex Gorsky takes the #EmbracingSustainability challenge
FINAL LEDE- Johnson & Johnson Chairman and CEO Alex Gorsky Takes the #EmbracingSustainability Challenge- Alex Gorsky hero

Johnson & Johnson Chairman and CEO Alex Gorsky takes the #EmbracingSustainability challenge

A new Business Roundtable campaign is challenging America’s top CEOs to shine a light on how they’re doing their part to help improve the health of the environment.

For more than 130 years, Johnson & Johnson has made it a mission to help keep people healthy. And since human health and environmental health are inextricably linked, the company is dedicated to helping keep the planet healthy, too.

Take its commitments to achieving the United Nations 2030 Sustainable Development Goals, its own Health for Humanity 2020 Goals and, most recently, Johnson & Johnson Consumer Inc.‘s decision to sign on as a charter member of the New Plastics Economy Global Commitment, which includes a pledge to use more recycled materials in its packaging.

It’s clear that sustainability is a top priority for Johnson & Johnson, which is why Chairman and CEO Alex Gorsky accepted an invitation this week from John Visentin, Vice Chairman and CEO of Xerox Corporation, to share just why it’s so important to the company as part of the new #EmbracingSustainability Challenge. The viral campaign was launched by Business Roundtable—an association of CEOs from America’s top companies—to show how corporate leaders are working to create a more environmentally, and economically, sustainable future.

In this video, Gorsky highlights just a few of the many ways Johnson & Johnson is doing just that—and passes the challenge baton to Chuck Robbins, Chairman and CEO of Cisco.


More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.